OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea · Delayed Price · Currency is KRW 6,980.00
+110.00 (1.60%)
Last updated: Oct 31, 2025, 9:51 AM KST
OPTUS Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 9,506 | 10,308 | 10,760 | 5,012 | 9,892 | 14,405 | Upgrade |
Depreciation & Amortization | 4,255 | 3,977 | 4,238 | 3,463 | 2,423 | 2,585 | Upgrade |
Loss (Gain) From Sale of Assets | -5.61 | 2.15 | -295.22 | -796.74 | -10.25 | - | Upgrade |
Loss (Gain) From Sale of Investments | -1,201 | -1,686 | -2,301 | 566.27 | 930.99 | -2,486 | Upgrade |
Stock-Based Compensation | -222.97 | 519.16 | 81.41 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | -0.01 | 0.02 | -15.04 | -0.09 | - | - | Upgrade |
Other Operating Activities | 2,901 | 2,069 | 2,771 | 646.69 | -397.52 | 2,935 | Upgrade |
Change in Accounts Receivable | -729.41 | -4,171 | -1,852 | -1,151 | -2,438 | 3,433 | Upgrade |
Change in Inventory | -3,547 | -77.42 | -1,800 | -2,112 | -3,043 | -928.45 | Upgrade |
Change in Accounts Payable | 139.27 | 1,235 | 352.75 | 17.23 | 306.46 | 95.21 | Upgrade |
Change in Other Net Operating Assets | -1,957 | -3,272 | 497.8 | -3,601 | -592.48 | -2,593 | Upgrade |
Operating Cash Flow | 9,138 | 8,905 | 12,438 | 2,045 | 7,071 | 17,446 | Upgrade |
Operating Cash Flow Growth | -31.87% | -28.41% | 508.12% | -71.08% | -59.47% | 3.66% | Upgrade |
Capital Expenditures | -22,728 | -11,808 | -3,329 | -6,001 | -10,628 | -5,842 | Upgrade |
Sale of Property, Plant & Equipment | 5 | 10.82 | 683.79 | 1,292 | 2.9 | - | Upgrade |
Sale (Purchase) of Intangibles | -9,064 | -13,932 | - | - | - | - | Upgrade |
Investment in Securities | 18,500 | 27,990 | -173.08 | -10,998 | -4,606 | -5,893 | Upgrade |
Other Investing Activities | -0 | -16.3 | -78.03 | -536.23 | 12.32 | 20 | Upgrade |
Investing Cash Flow | -13,250 | 2,290 | -2,929 | -16,266 | -15,223 | -6,410 | Upgrade |
Short-Term Debt Issued | - | 1 | - | - | - | 2 | Upgrade |
Total Debt Issued | - | 1 | - | - | - | 2 | Upgrade |
Short-Term Debt Repaid | - | -1 | - | - | - | -2 | Upgrade |
Long-Term Debt Repaid | - | -730.47 | -588.39 | -364.67 | -111.24 | -108.86 | Upgrade |
Total Debt Repaid | -739.87 | -731.47 | -588.39 | -364.67 | -111.24 | -110.86 | Upgrade |
Net Debt Issued (Repaid) | -739.87 | -730.47 | -588.39 | -364.67 | -111.24 | -108.86 | Upgrade |
Issuance of Common Stock | 101.17 | 117.57 | - | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | - | -5,958 | - | -2,020 | Upgrade |
Dividends Paid | - | -1,526 | -1,517 | -1,604 | -1,604 | -1,632 | Upgrade |
Other Financing Activities | 0 | - | - | - | - | - | Upgrade |
Financing Cash Flow | -638.7 | -2,139 | -2,105 | -7,927 | -1,715 | -3,761 | Upgrade |
Foreign Exchange Rate Adjustments | 84.14 | 39.17 | -2.25 | 1.05 | - | -8.9 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | -0 | - | Upgrade |
Net Cash Flow | -4,667 | 9,095 | 7,402 | -22,146 | -9,867 | 7,266 | Upgrade |
Free Cash Flow | -13,590 | -2,903 | 9,109 | -3,955 | -3,557 | 11,603 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | -10.91% | Upgrade |
Free Cash Flow Margin | -16.41% | -3.55% | 12.58% | -6.74% | -6.21% | 19.08% | Upgrade |
Free Cash Flow Per Share | -889.39 | -190.11 | 599.36 | -249.37 | -221.87 | 719.32 | Upgrade |
Cash Interest Paid | - | 0 | 120.16 | 83.85 | - | 0 | Upgrade |
Cash Income Tax Paid | 1,366 | 2,175 | 930.79 | 2,094 | 2,075 | 2,871 | Upgrade |
Levered Free Cash Flow | -15,817 | -11,169 | 5,838 | -4,902 | -4,264 | 13,314 | Upgrade |
Unlevered Free Cash Flow | -15,766 | -11,108 | 5,915 | -4,848 | -4,258 | 13,325 | Upgrade |
Change in Working Capital | -6,094 | -6,285 | -2,801 | -6,846 | -5,767 | 6.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.